Cogent Biosciences (COGT) Change in Receivables (2017 - 2020)
Historic Change in Receivables for Cogent Biosciences (COGT) over the last 4 years, with Q1 2020 value amounting to -$2.0 million.
- Cogent Biosciences' Change in Receivables fell 63763.44% to -$2.0 million in Q1 2020 from the same period last year, while for Dec 2020 it was -$2.0 million, marking a year-over-year decrease of 70240.96%. This contributed to the annual value of -$2.0 million for FY2020, which is 70240.96% down from last year.
- Per Cogent Biosciences' latest filing, its Change in Receivables stood at -$2.0 million for Q1 2020, which was down 63763.44% from $1.1 million recorded in Q4 2019.
- In the past 5 years, Cogent Biosciences' Change in Receivables registered a high of $1.1 million during Q4 2019, and its lowest value of -$2.0 million during Q1 2020.
- Over the past 4 years, Cogent Biosciences' median Change in Receivables value was $217000.0 (recorded in 2018), while the average stood at -$71384.6.
- Per our database at Business Quant, Cogent Biosciences' Change in Receivables surged by 198048.78% in 2018 and then plummeted by 63763.44% in 2020.
- Quarter analysis of 4 years shows Cogent Biosciences' Change in Receivables stood at -$681000.0 in 2017, then surged by 136.56% to $249000.0 in 2018, then surged by 349.8% to $1.1 million in 2019, then tumbled by 278.57% to -$2.0 million in 2020.
- Its Change in Receivables stands at -$2.0 million for Q1 2020, versus $1.1 million for Q4 2019 and -$612000.0 for Q3 2019.